5 active not recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SPG302 in Adults With Schizophrenia SPG302, Placebo - Schizophrenia | Phase 2 | Active not recruiting | Spinogenix | 32 | 2024-08-01 | 2026-02-06 |
| A Study of ANAVEX3-71 in Adults With Schizophrenia ANAVEX3-71 oral capsules, Placebo oral capsules - Schizophrenia | Phase 2 | Active not recruiting | Anavex Life Sciences Corp. | 71 | 2024-03-15 | 2025-05-04 |
| Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders Dasatinib, quercetin - Schizophrenia, Treatment Resistant Depression | Phase 2 | Active not recruiting | Washington University School of Medicine | 40 | 2023-07-01 | 2026-04-21 |
| Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1) Ketamine Hydrochloride - Healthy | Phase 1 / Phase 2 | Active not recruiting | New York State Psychiatric Institute | 35 | 2021-01-01 | 2026-07-13 |
| Enhancing Recovery in Early Schizophrenia Cannabidiol as add-on, Placebo as add-on - Schizophrenia | Phase 2 | Active not recruiting | Central Institute of Mental Health, Mannheim | 180 | 2017-04-08 | 2026-02-03 |
Aging, Premature (1) · Depressive Disorder, Treatment-Resistant (1)
Mental Disorders (5) · Schizophrenia Spectrum and Other Psychotic Disorders (5) · Depressive Disorder (1) · Mood Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Cannabidiol (1) · Dasatinib (1) · Ketamine (1) · Quercetin (1)
Anavex Life Sciences Corp. (1) · Central Institute of Mental Health, Mannheim (1) · New York State Psychiatric Institute (1) · Spinogenix (1) · Washington University School of Medicine (1)
United States (4) · Australia (1) · Germany (1)
David Walling, MD (1) · Eric Lenze, MD (1) · F. Markus Leweke, MD (1)
R01MH123142 (1)